Authors:
Giles, FJ
Shen, Y
Kantarjian, HM
Korbling, MJ
O'Brien, S
Anderlini, P
Donato, M
Pierce, S
Keating, MJ
Freireich, EJ
Estey, E
Citation: Fj. Giles et al., Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival, LEUK LYMPH, 42(1-2), 2001, pp. 67-73
Authors:
Fleming, RV
Kantarjian, HM
Husni, R
Rolston, K
Lim, J
Raad, I
Pierce, S
Cortes, J
Estey, E
Citation: Rv. Fleming et al., Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 511-520
Authors:
Cha, S
Pierce, S
Knopp, EA
Johnson, G
Yang, C
Ton, A
Litt, AW
Zagzag, D
Citation: S. Cha et al., Dynamic contrast-enhanced T2-weighted MR imaging of tumefactive demyelinating lesions, AM J NEUROR, 22(6), 2001, pp. 1109-1116
Authors:
Albitar, M
Manshouri, T
Gidel, C
Croce, C
Kornblau, S
Pierce, S
Kantarjian, HM
Citation: M. Albitar et al., Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia, LEUK RES, 25(10), 2001, pp. 859-864
Authors:
Bennett, BL
Sasaki, DT
Murray, BW
O'Leary, EC
Sakata, ST
Xu, WM
Leisten, JC
Motiwala, A
Pierce, S
Satoh, Y
Bhagwat, SS
Manning, AM
Anderson, DW
Citation: Bl. Bennett et al., SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase, P NAS US, 98(24), 2001, pp. 13681-13686
Authors:
Ibrahim, S
Estey, EH
Pierce, S
Glassman, A
Keating, M
O'Brien, S
Kantarjian, HM
Albitar, M
Citation: S. Ibrahim et al., 11q23 Abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses, AM J CLIN P, 114(5), 2000, pp. 793-797
Citation: Fj. Giles et al., Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 87-95
Authors:
Kantarjian, HM
O'Brien, S
Smith, TL
Cortes, J
Giles, FJ
Beran, M
Pierce, S
Huh, Y
Andreeff, M
Koller, C
Ha, CS
Keating, MJ
Murphy, S
Freireich, EJ
Citation: Hm. Kantarjian et al., Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia, J CL ONCOL, 18(3), 2000, pp. 547-561
Citation: Eh. Estey et al., Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities, HAEMATOLOG, 85(3), 2000, pp. 246-249
Authors:
Keyhani, A
Huh, YO
Jendiroba, D
Pagliaro, L
Cortez, J
Pierce, S
Pearlman, M
Estey, E
Kantarjian, H
Freireich, EJ
Citation: A. Keyhani et al., Increased CD38 expression is associated with favorable prognosis in adult acute leukemia, LEUK RES, 24(2), 2000, pp. 153-159
Authors:
Mehndiratta, S
Kemp, M
Pierce, S
Lappin, J
Citation: S. Mehndiratta et al., Users of a regional telephone-based traveler information system - a study of TravInfo (TM) users in the San Francisco Bay Area, TRANSPORTAT, 27(4), 2000, pp. 391-417
Citation: S. Pierce et al., Architectural and physiological heterogeneity within the synflorescence ofthe pseudoviviparous grass Poa alpina var. vivipara L., J EXP BOT, 51(351), 2000, pp. 1705-1712
Citation: S. Pierce et al., The influence of secondary senescence processes within the culm of a pseudoviviparous grass (Poa alpina var. vivipara L.) on the supply of water to propagules, J EXP BOT, 51(347), 2000, pp. 1067-1075
Authors:
Faderl, S
Kantarjian, HM
Estey, E
Manshouri, T
Chan, CY
Elsaied, AR
Kornblau, SM
Cortes, J
Thomas, DA
Pierce, S
Keating, MJ
Estrov, Z
Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia, CANCER, 89(9), 2000, pp. 1976-1982
Authors:
Kaban, K
Kantarjian, H
Talpaz, M
O'Brien, S
Cortes, J
Giles, FJ
Pierce, S
Albitar, M
Citation: K. Kaban et al., Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia - Correlation with disease progression and response to therapy, CANCER, 88(3), 2000, pp. 570-576
Authors:
Faderl, S
Estrov, Z
Kantarjian, HM
Thomas, D
Cortes, J
Manshouri, T
Chan, CC
Hays, KJ
Pierce, S
Albitar, M
Citation: S. Faderl et al., The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia, CYTOK CELL, 5(3), 1999, pp. 159-163
Authors:
Faderl, S
Kantarjian, HM
Manshouri, T
Chan, CY
Pierce, S
Hays, KJ
Cortes, J
Thomas, D
Estrov, Z
Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) and p15(INK4b) deletions in adult acute lymphoblastic leukemia, CLIN CANC R, 5(7), 1999, pp. 1855-1861
Authors:
Faderl, S
Thall, PF
Kantarjian, HM
Talpaz, M
Harris, D
Van, Q
Beran, M
Kornblau, SM
Pierce, S
Estrov, Z
Citation: S. Faderl et al., Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia, CLIN CANC R, 5(12), 1999, pp. 4041-4047
Authors:
Estey, EH
Thall, PF
Reed, P
Kantarjian, H
Beran, M
Pierce, S
Keating, MJ
Citation: Eh. Estey et al., Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapy, LEUKEMIA, 13(6), 1999, pp. 850-854